+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Biden administration tells COVID-19 test manufacturers that demand for tests could double or triple in coming months with Omicron variant

Dec 16, 2021, 09:28 IST
Business Insider
A man takes a COVID-19 test at Sydney International Airport on November 28, 2021.James D. Morgan/Getty Images
  • Biden administration officials are concerned that demand for testing could strain supply, Politico reported.
  • The concerns come as the Omicron variant could lead to COVID-19 case surges throughout the US.
Advertisement

Officials in the Biden administration are telling COVID-19 test manufacturers that demand for tests could rapidly surge in the coming months due to the Omicron coronavirus variant, Politico reported Wednesday.

Sources told Politico the Health and Human Services Department determined the test supply in the US could fall short by late January and early February, when they expect demand to reach 3 to 5 million tests per day.

Daily testing levels fluctuate but currently are more than 1.6 million, according to data tracked by Johns Hopkins University, though many at-home tests are not reported to public health agencies.

One source told Politico that demand projection depends on if Omicron turns out to be significantly more transmissible than Delta.

Scientists are still evaluating the implications of the Omicron variant. Early data indicates it may cause less severe illness than other variants but that "a lot of people" will still get sick, Centers for Disease Control and Prevention Director Rochelle Walensky said Tuesday.

Advertisement

Omicron was first detected in the US on November 15. Walensky said most people in the US with confirmed cases of the variant have experienced mild symptoms, like cough, congestion, and fatigue. However early data also suggests the variant could be highly transmissible and able to evade the protection offered by the vaccines.

The Health and Human Services Department did not immediately respond to Insider's request for comment, but one official told Politico they are "modeling for a range of scenarios to prepare for potential future public health needs."

"Testing demand involves many behavioral variables, but we are focused on preparedness and continuing to make sure plenty of tests are available along with vaccines, boosters, and other tools to help protect the American people," the official said.

Have a news tip? Contact this reporter at kvlamis@insider.com.

You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article